Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2026-02-05 @ 10:48 PM
Study NCT ID:
NCT01606761
Status:
COMPLETED
Last Update Posted:
2018-03-23
First Post:
2012-05-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)
Sponsor:
Janssen Research & Development, LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Arthritis, Rheumatoid | View |